Cancer Treatment: ABP 234 vs. Keytruda

We are comparing a new treatment called ABP 234 with Keytruda for patients with cancer. This study aims to see which option may be more effective in managing the disease.

>2 yearsSafety phase (I)OncologyPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Landeskrankenanstalten-Betriebsgesellschaft Kabeg
Department of pulmonary diseases
Klagenfurt am Wörthersee, Austria
Ordensklinikum Linz GmbH
Pneumology
Linz, Austria
Klinik Hietzing
Klinik Hietzing 5. Med. Abteilung Pavillon 3
Perchtoldsdorf, Austria

Sponsor: Amgen Inc.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.